We analyzed gene expression data of 140 (training set) and 78 (test set) pediatric samples carrying ALL (N = 106+62) and AML (N = 34+16), with (N = 24+13) and without (N = 116+65) MLL translocations. This evidence concerns the gene KMT2A and acute myeloid leukemia.